Piper Sees Medical Search News Impacting Baidu's (BIDU) '09 Sales by 1-3%
More News related to BIDU
- Qtrax Announces Partnership With Baidu
- Top 10 News Items: 9/26-9/30: Q3 GDP Surprises to the Upside; Dollar Still Dominating Market Action; VIX Spikes Sharply, Now Over 30
- Don't Miss Out! The Registration Period for the 2010 IR Global Rankings Ends TOMORROW!
- Highlights From BIDU's Q3 Conference Call: Phoenix Nest Contributed 20% of Overall Revenues, But Sees Q4 Below Consensus
- Morning Movers 10/27: HPGP, HLND, TBAC, CTDC, PODD, HSII Higher; ICGN, AMFI, IBCP, CRI, SGMS, PVTB Lower
More News related to Analyst Comments
- Merriman Curhan Ford Reiterates a 'Buy' on Regeneron (REGN); Raising Target Range
- Credit Suisse Hikes Target on Vale (VALE) to $34; Sees 91% Jump in Profits Next Year
- S&P Raises Red Hat's (RHT) Corporate Credit Rating to 'BB+'
- S&P Places Sprint Nextel (S) Credit Rating On CreditWatch Negative
- Palm (PALM) Shares Rallying as Analysts Gaining Confidence
Following a weekend report by China's CCTV related to Baidu.com's (Nasdaq: BIDU) paid search marketing tactics, Piper Jaffray is out with a research note considering the financial impact of such a development at the Chinese search-giant.
While the firm believes that there will be some impact on Baidu's financials, it sees the impact as likely being "less than first take." Piper maintains its Buy rating and $468 price target on shares of Baidu.com.
Piper sees the news impacting Baidu's CY09 sales by 1-3%, given that "pharma and medical keywords make up only a small portion of total keywords sold..." Outside changes made to Baidu's ads for medical sites, the firm does not expect significant changes to the company's sales practices.
Piper said its $468 price target on Baidu is based on 64x the firm's FY09 GAAP EPS estimate.
Baidu.com, Inc., through its subsidiaries, provides Chinese language Internet search services primarily in the People's Republic of China.
Related Categories
Analyst CommentsCorporate News
Insiders' Blog
Stocks Mentioned
-1.09Related Entities
Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
hehe
shawn wong on Nov 18, 2008 02:47 AMPiper seems has no ideal about china.What baidu did is a disaster.